IGF‑1 and VEGF can be used as prognostic indicators for patients with uterine fibroids treated with uterine artery embolization

Okogbo FO, Ezechi OC, Loto OM and Ezeobi PM: Uterine Leiomyomata in South Western Nigeria, A clinical study of presentations and management outcome. Afr Health Sci. 11:271–278. 2011.PubMed/NCBI

Zhang Y, Sun L, Guo Y, Cheng J, Wang Y, Fan S and Duan H: The impact of preoperative gonadotropin-releasing hormone agonist treatment on women with uterine fibroids, A meta-analysis. Obstet Gynecol Surv. 69:100–108. 2014. View Article : Google Scholar : PubMed/NCBI

Wang A and Yin S: Controversy and challenge in the treatment methods of uterine fibroids. Zhong Guo Quan Ke Yi Xue. 12:14–15. 2009.(In Chinese).

Singh C, Gupta M, Tripathi R and Tyagi S: Successful use of transcatheter embolisation in an emergent life-threatening situation of bleeding from uterine arteriovenous malformation. BMJ Case Rep. 2013:2013.

Mathonnet M, Descottes B, Valleix D, Labrousse F, Truffinet V and Denizot Y: Quantitative analysis using ELISA of vascular endothelial growth factor and basic fibroblast growth factor in human colorectal cancer, liver metastasis of colorectal cancer and hepatocellular carcinoma. World J Gastroenterol. 12:3782–3783. 2006.PubMed/NCBI

Fan ZR, Yang DH, Zuo HR, Xu Z and Qiu QL: Expressions of IGF-I, IGF-II and their receptor mRNAs in hepatocellular carcinomas and adjacent non-tumor tissues. Ai Zheng. 19150–152. (155)2000.(In Chinese).

Pourgholami MH and Morris DL: Inhibitors of vascular endothelial growth factor in cancer. Cardiovasc Hematol Agents Med Chem. 6:343–347. 2008. View Article : Google Scholar : PubMed/NCBI

Dai B, Wang DS, Zhang Y, Zhou L, Liu J and Sun W: The role of insulin-like growth factors in tumor. Zhong Hua Lin Chuang Yi Shi Za Zhi (Dian Zi Ban). 7:7099–7102. 2013.(In Chinese).

Ding ZX, Zhang LZ and Ling L: Levels of matrix metalloproteinase and vascular endothelial growth factor in patients with primary liver cancer. Gan Zang. 10:214–215. 2005.(In Chinese).

Liao D, Fan Z and Huang R: Clinical Report of treating uterine fibroids and uterine adenomyosis with uterine artery embolization. Wei Chuang Yi Xue. 7:256–258. 2012.(In Chinese).

Gu J, Guan Q, Ji W and Ren W: The influence of serum HIF-1a and VEGF content on the prognosis in patients with hepatocellular carcinoma after TACE. Jie Ru Fang She Xue Za Zhi. 23:142–146. 2014.(In Chinese).

Marina O, Suh JH, Reddy CA, Barnett GH, Vogelbaum MA, Peereboom DM, Stevens GH, Elinzano H and Chao ST: Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Histopathology. J Neurosurg. 115:220–229. 2011. View Article : Google Scholar : PubMed/NCBI

Ahmad A, Qadan L, Hassan N and Najarian K: Uterine artery embolization treatment of uterine fibroids, effect on ovarian function in younger women. J Vasc Interv Radiol. 13:1017–1020. 2002. View Article : Google Scholar : PubMed/NCBI

Pelage JP, Cazejust J, Pluot E, Le Dref O, Laurent A, Spies JB, Chagnon S and Lacombe P: Uterine fibroid vascularization and clinical relevance to uterine fibroid embolization. Radiographics. 25((Suppl 1)): S99–S117. 2005. View Article : Google Scholar : PubMed/NCBI

Wang L: Clinical study of treating uterine fibroids with uterine artery embolization. Zhong Guo Yi Yao. 2:238–241. 2012.(In Chinese).

Qu W, Guo P and Wu Y: Clinical research of uterine artery embolization for symptomatic hysteromyoma. J Pract Med Tech. 18:573–576. 2011.

Ji W, Xin X and Chen B: The influence of insulin-like growth factor 1 and insulin-like growth factor 1 receptor on the growth of uterine leiomyoma. Zhong Guo Zhong Liu Lin Chuang Yu Kang Fu. 10:24–26. 2003.(In Chinese).